Since their approval in 2005, some clinicians have been cautious about prescribing GLP-1 receptor agonists (GLP-1 RAs), or weight loss drugs, to patients with very high triglycerides due to their elevated pancreatitis risk
With the deepening of clinical research, we expect that this kind of new drug can bring more comprehensive treatment benefits to the majority of diabetes patients
Wrapping practical advice into daily habits Small, consistent habits make the biggest difference: prefer powders or capsules if odor worries you, keep bottles sealed and cool, choose single-dose formats for liquids, and report suspect products
How often should I use GLUTIMAX-600
Despite these positive findings, one caveat is that we do not know the effects of this newer therapy on cardiovascular outcomes but this will be forthcoming in future trials